The Drum · Weekly AI news, freeSubscribe →
Share
Researchers are using machine learning to tailor blood test interpretations, moving away from generic reference ranges and toward more personalized patient care that accounts for individual differences.
If you’ve ever had a doctor order a blood test, there’s a good chance it was a complete blood count (CBC) test. One of the most common medical procedures worldwide, CBC tests are performed billions of times each year to diagnose conditions and monitor patients’ health. Despite their ubiquity, these tests often rely on one-size-fits-all reference intervals that may not accurately reflect individual differences.
Dr. Brody H. Foy, a mathematician at the University of Washington School of Medicine, along with colleagues from the Higgins Lab at Harvard Medical School, is leading research to change this. By leveraging machine learning, they aim to create more personalized and precise blood test interpretations, ultimately improving patient care and predicting future health risks.
Currently, CBC tests measure various components of your blood, including red blood cells, white blood cells, and platelets. These measurements are compared against standard reference ranges that apply to the general population. However, this approach can be problematic because it doesn’t account for individual variations in health and physiology.
For example, what might be a normal hemoglobin level for one person could indicate anemia or another condition in someone else. This lack of personalization can lead to misdiagnoses and missed opportunities for early intervention.
To address these limitations, Dr. Foy’s team analyzed 20 years of blood count data from tens of thousands of patients across the East and West coasts. Using advanced machine learning algorithms, they were able to identify healthy blood count ranges specific to individual patients. This approach allows for a more nuanced understanding of what "normal" looks like for each person.
“Machine learning can help us capture the unique biological signatures of individual patients,” Dr. Foy explains. “By doing so, we can make blood tests more accurate and reliable.”
Beyond improving current diagnostic capabilities, machine learning can also predict future health risks. The research team found that by analyzing long-term trends in blood count data, they could identify patterns that indicate a higher risk of developing certain conditions.
For instance, subtle changes in white blood cell counts over time might signal an increased likelihood of infections or inflammatory diseases. By detecting these early warning signs, healthcare providers can take proactive steps to prevent or manage potential health issues.
The implications of this research are significant for both patients and healthcare providers. Personalized blood test interpretations can lead to more accurate diagnoses, better treatment plans, and improved patient outcomes. For example, a patient with borderline anemia might receive tailored dietary recommendations or medication adjustments based on their unique blood profile.
Moreover, the ability to predict future health risks can help doctors prioritize preventive care. This is particularly important for chronic conditions like diabetes and heart disease, where early intervention can make a substantial difference in long-term health.
While the potential benefits are clear, there are also challenges to consider. Implementing machine learning in clinical settings requires robust data infrastructure and trained personnel to interpret the results. Additionally, ensuring patient privacy and data security is crucial as sensitive health information is involved.
Dr. Foy acknowledges these concerns but remains optimistic about the future. “With continued research and collaboration between healthcare providers and technologists, we can overcome these challenges and bring more personalized care to patients.”
The next steps for Dr. Foy’s team include expanding their dataset and refining their machine learning models. They are also working with hospitals and clinics to integrate these tools into clinical practice.
As this technology advances, it has the potential to transform how we think about blood tests and patient care. By making blood tests more personalized and predictive, we can move closer to a future where healthcare is tailored to each individual’s unique needs.
Tags
Original Sources
About the author
Amara's entry point into AI was an epidemiology role at a London research hospital, where she spent five years studying how digital health tools reached — or conspicuously failed to reach — underserved communities. Watching early algorithmic systems in healthcare quietly entrench existing inequalities, she redirected her career toward the systemic consequences of AI at scale. She covers AI through an unflinching lens: who benefits, who bears the cost, and what evidence actually says versus what the press release claims. Her writing is calm and precise, but she doesn't mistake balance for neutrality.
More from The Steward →This Week's Edition
20 December 2024
133 articles
Related Articles
Related Articles
More Stories
